MedTrace Logo

Behavioral Therapy Development for Methamphetamine Abuse

NCT00252434 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2016-01-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using methamphetamines, reduce sexual risk behaviors, and stay on their HIV medications than a standard drug treatment program. Another purpose is to determine whether having a drug abuse treatment program in an HIV medical clinic makes it easier to attend treatment than going to a separate location for drug abuse treatment.

Conditions

  • Depression
  • Drug Abuse
  • Sexually Transmitted Diseases

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy Development for Methamphetamine Abuse

Sponsors & Collaborators

Principal Investigators

  • James A. Peck, PsyD. · UCLA Integrated Substance Abuse Programs

  • James A Peck, Psy.D. · UCLA Integrated Substance Abuse Programs

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00252434 on ClinicalTrials.gov